Company intelligence / Profile preview

ASP Isotopes

Washington, DC, United Statesaspisotopes.com ↗

Ownership: Private
Employees: ~136
Development stage: Commercial

Overview

ASP Isotopes has begun commercial production of key medical and research isotopes such as Molybdenum–100 and Carbon–14 at its South African facilities. The company is expanding capacity to meet global demand due to supply chain disruptions from geopolitical events. Other programs are at various stages of development or commissioning.

Therapeutic areas: Other
Modalities: RadiopharmaceuticalDiagnostic agentSmall moleculeEnriched stable and radioactive isotopes
Industry: Chemicals & Materials

Partnerships

Government agenciesPotential partners

Beyond the preview

Go deeper on ASP Isotopes.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ASP Isotopes.

Explore the full profile